Black Hawk Acquisition Corp
BKHAU- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002000775
No open-market purchases or sales by Black Hawk Acquisition Corp insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $232.1K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Black Hawk Acquisition Corp as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −11 vs. Q2 2024
- Shares held
- 344.1K
- −837.2K (−70.9%) vs. Q2 2024
- Total value
- $3.62M
- −$8.58M (−70.3%) vs. Q2 2024
- New holders
- 0
- 0 more added
- Sold out
- 11
- 1 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BKHAU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 3 | $232.1K |
| Q1 2026 | 3 | $49.1K |
| Q4 2025 | 1 | $27.6K |
| Q3 2025 | 1 | $35.6K |
| Q2 2025 | 1 | $34.8K |
| Q1 2025 | 4 | $1.61M |
| Q4 2024 | 7 | $2.36M |
| Q3 2024 | 9 | $3.62M |
| Q2 2024 | 20 | $12.2M |
| Q1 2024 | 43 | $57.5M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Black Hawk Acquisition Corp; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 100,000 | $1.05M | 0.03% | 00.0% | Unchanged |
| Yakira Capital Management, Inc. | 89,984 | $942.3K | 0.37% | 00.0% | Unchanged |
| HGC Investment Management Inc. | 50,000 | $527.8K | 0.22% | 00.0% | Unchanged |
| Westchester Capital Management, LLC | 50,000 | $520.5K | 0.02% | 00.0% | Unchanged |
| Gabelli & Co Investment Advisers, Inc. | 23,400 | $247.0K | 0.04% | 00.0% | Unchanged |
| Gabelli Funds LLC | 22,481 | $237.3K | 0.00% | 00.0% | Unchanged |
| Longfellow Investment Management Co LLC | 7,555 | $79.8K | 0.02% | 00.0% | Unchanged |
| Clear Street LLC | 345 | $3.64K | 0.00% | −224,347−99.8% | Reduced |
| Tower Research Capital LLC (TRC) | 344 | $3.62K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 0 | $0 | 0.00% | −128,000−100.0% | Sold out |
| Meteora Capital, LLC | 0 | $0 | 0.00% | −105,000−100.0% | Sold out |
| Periscope Capital Inc. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| MMCAP International Inc. SPC | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −72,000−100.0% | Sold out |
| Rivernorth Capital Management, LLC | 0 | $0 | 0.00% | −63,015−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −24,591−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −100−100.0% | Sold out |